ELS Team in FDAnews

Dr. Vijai Kumar and Dan McDonald were quoted in a May 29, 2008 article in Clinical Trial Advisor (www.FDAnews.com) titled “Indian Clinical Trials Market Booming, Experts Say”.

Click here to read the full article.

ELS Welcomes Industry Veteran Wayne Pines to Board of Directors

ELS is pleased to announce the addition of regulatory affairs and drug development industry veteran Wayne Pines to its Board of Directors. Pines is an internationally-recognized consultant on regulatory issues, advertising and promotion, media strategies and crisis management involving pharmaceuticals, biological products and medical devices. He is President of Regulatory Services and Healthcare at APCO Worldwide in Washington, D.C and also serves as President of the Alliance for a Stronger FDA, a Washington-area NGO. Pines previously served as Associate Commissioner for Public Affairs at the FDA. He has published a dozen books about FDA regulatory processes and crisis management.

Click here for the full release.

US pharma industry to adopt Indian standards

When you find that the quality standard mentioned on a US multinational drug maker’s AIDS drug label reads Indian Pharmacopoeia, or IP, next time, don’t be surprised.

It’s official now: The US drug industry would follow the standards for HIV/AIDS drugs as per the quality parameters prescribed in the drug standards manual prepared by the Indian Pharmacopoeia Commission.

Click here to read the full article.

Center Watch Weekly Publishes Interview with Dr. Vijai Kumar, President and CMO

Center Watch Weekly profiles ELS, a US based, India focused, Pharmaceutical Research Organization.  Dr. Kumar descibes the evolving state of clinical research in India, the challenges India faces and the solutions required for conducting efficient and ethical trials in this emerging market.

Applied Clinical Trials Publishes Article Written by Dan Mcdonald, VP Business Strategy

Dan McDonald, vice president of business development for Excel Life Sciences, assesses the role of Site Management Organizations (SMOs) in India and discusses their contributions, which include GCP training and assistance for investigators.

Click here to read the entire article.

ELS Launches New Website

ELS launched its completely redesigned and enhanced web site. With a totally fresh appearance and format, the new web site contains more customer-oriented information on our therapeutic expertise and solutions while also offering improved usability and visual appeal. Visit our new site at www.ExcelLifeSciences.com.

ELS Personnel Moves Picked-up By Major Industry Publishers CenterWatch and Applied Clinical Trials

The addition of two senior executives to the Excel Life Sciences team, Wayne Pines to the Board of Directors and Dan McDonald as VP, Business Strategy was recently covered by two of the drug development industries premier publications CenterWatch and Applied Clinical Trials magazine.

The moves were included in CenterWatch’s ClinicalTrialsToday.com industry Weblog on December 17th. Click here to see the post.

Applied clinical trials magazine posted announcements in their January issue along with headshots of both individuals.